Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20261Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Pavlidis, N. A. | en |
| dc.contributor.author | Drosos, A. A. | en |
| dc.contributor.author | Papadimitriou, C. | en |
| dc.contributor.author | Talal, N. | en |
| dc.contributor.author | Moutsopoulos, H. M. | en |
| dc.date.accessioned | 2015-11-24T19:05:53Z | - |
| dc.date.available | 2015-11-24T19:05:53Z | - |
| dc.identifier.issn | 0098-1532 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20261 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Aged, 80 and over | en |
| dc.subject | Autoimmune Diseases/*complications | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Immunoenzyme Techniques | en |
| dc.subject | Lymphoma, Non-Hodgkin/*etiology/pathology | en |
| dc.subject | Middle Aged | en |
| dc.subject | Remission, Spontaneous | en |
| dc.subject | Sjogren's Syndrome/*complications | en |
| dc.title | Lymphoma in Sjogren's syndrome | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/1608349 | - |
| heal.identifier.secondary | http://onlinelibrary.wiley.com/store/10.1002/mpo.2950200403/asset/2950200403_ftp.pdf?v=1&t=h0m30z1z&s=0b5bf35c0ada7e71ee6f1e3eba030b702f9d562c | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1992 | - |
| heal.abstract | Sjogren's syndrome is an autoimmune disease with a known predisposition for lymphoma development. Eight of 120 patients with primary Sjogren's syndrome followed at the University of Ioannina over the past 7 years developed non-Hodgkin's lymphoma diagnosed according to the Kiel classification. The lymphomas differed by location and grading. Six were called low grade (immunocytoma) and two intermediate grade non-Hodgkin's lymphomas. Five of the immunocytomas involved the minor salivary or lacrimal glands. Immunoperoxidase staining for light chains revealed monoclonal populations. Two patients showed spontaneous regression not previously reported in Sjogren's syndrome. Thus, in Sjogren's syndrome, low grade non-Hodgkin's lymphomas and especially immunocytomas are the most common lymphomas. These lymphomas tend to evolve very slowly and may regress spontaneously. Given these facts, a conservative approach to treatment is indicated in those patients with only localized disease. | en |
| heal.journalName | Med Pediatr Oncol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pavlidis-1992-Lymphoma in Sjogren'.pdf | 828.4 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
